Evaluation of Industry Canada's Contribution to Genome Canada

Evaluation Purpose and Methodology In accordance with the Treasury Board Policy on Evaluation and the Directive on the Evaluation Function, the purpose of this evaluation was to assess the core issues of relevance and performance of Industry Canada’s contribution to Genome Canada. [...] In response to the findings of this evaluation, and consistent with the finding of the Science Metrix evaluation, it is recommended that: 1. Industry Canada’s Science and Innovation Sector (SIS) work with Genome Canada as required on defining and measuring concepts related to translational and socio-economic impacts based on the expected results of the funding agreement. [...] The evaluation assessed the relevance and performance of the contribution to Genome Canada in accordance with the requirements of the Treasury Board Policy on Evaluation. [...] The funding agreements between Industry Canada and Genome Canada set out the obligations of both parties vis-à-vis the contributions, including Genome Canada’s obligations in transferring funds to the Genome Centres. [...] Of the funding provided to Genome Canada, approximately $6.6 million is allotted annually to support its salary and O&M costs, and $4.8 million to support a portion of the salary and O&M costs of the six Genome Centres.